Nicotine / THR - Statements from Experts: Difference between revisions
Jump to navigation
Jump to search
Line 317: | Line 317: | ||
<br> | <br> | ||
===Patricia Kovacevic, | ===Patricia Kovacevic, JD=== | ||
*[https://twitter.com/patriciakova Follow on Twitter] | *[https://twitter.com/patriciakova Follow on Twitter] / [https://tobaccoreporter.com/2022/04/05/women-in-tobacco-to-meet-in-paris/ Photo] / [https://regulationstrategy.com/patricia-kovacevic/ Bio] / [https://twitter.com/patriciakova/status/1610989194410692608 Quote Source] | ||
* | *Disclosures: General Counsel and Chief Compliance Officer, Nicopure Labs, 2015 - 2020, General Counsel to Lorrilard and PMI 2004 - 2015 | ||
<br> | <br> | ||
[[file:UK US Patricia Kovacevic, JD.png|center]] | |||
<br> | <br> | ||
===Floe Foxon, BSc=== | ===Floe Foxon, BSc=== | ||
*[https://twitter.com/FloeFoxon Follow on Twitter] / [https://twitter.com/FloeFoxon/status/1448302299013582849 Quote Source] / [https://floefoxon.github.io/ Photo] / [https://www.pinneyassociates.com/team/floe-foxon/ Bio] | *[https://twitter.com/FloeFoxon Follow on Twitter] / [https://twitter.com/FloeFoxon/status/1448302299013582849 Quote Source] / [https://floefoxon.github.io/ Photo] / [https://www.pinneyassociates.com/team/floe-foxon/ Bio] |